Showing 10 of 10 recruiting trials for “Hemophagocytic Lymphohistiocytosis”
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
👨⚕️ Xuefeng He, doctor, department of hematology, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Nov 2025View details ↗
Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
👨⚕️ Jerry Lee, MD, University of California, San Francisco📍 2 sites📅 Started Oct 2024View details ↗
RecruitingNCT06339177 ↗
Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
👨⚕️ Joseph M Rocco, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 2 sites📅 Started Jul 2024View details ↗
RecruitingNCT06614998 ↗
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
RecruitingNCT06585124 ↗
Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas
👨⚕️ Stefan Hohaus, MD, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started May 2024View details ↗
Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection
RecruitingNCT05898477 ↗
Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
RecruitingNCT05277272 ↗
INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)
👨⚕️ Michael Jordan, MD, Children's Hospital Medical Center, Cincinnati📍 1 site📅 Started Dec 2021View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →